| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |